intellectual property issues in a clinical trial: a corporate perspective.

NLM AIDSLINE Intellectual property issues in a clinical trial: a corporate perspective. Fersko RS; Connolly MJ; Tanner Propp & Fersko, New York, New York 10016.
July 30, 1994

Qual Assur. 1992 Jun;1(3):237-48. Unique Identifier : AIDSLINE Acquired Immunodeficiency Syndrome/THERAPY Clinical Trials/LEGISLATION & JURISPRUD Confidentiality/LEGISLATION & JURISPRUD Conflict of Interest/LEGISLATION & JURISPRUD Drug Industry/ORGANIZATION & ADMIN Financing, Government/LEGISLATION & JURISPRUD Health Policy/LEGISLATION & JURISPRUD Human Interinstitutional Relations National Institutes of Health (U.S.)/ORGANIZATION & ADMIN Patents/LEGISLATION & JURISPRUD Research Support/LEGISLATION & JURISPRUD United States JOURNAL ARTICLE

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 Positive living Lawyer: NY man at center of HIV scare not positive Zimbabwe activist: Prisoners denied AIDS drugs Youth organizations form a pact for social transformation in the AIDS response Kingdom of Bahrain and UNAIDS commit to intensify cooperation CANADA: Celibate Homosexual Men Now Allowed to Donate Blood in Canada AFRICA: UN: AIDS Deaths Down, Treatment Up in Africa MICHIGAN: STD Fee for Jackson County Walk-In Clinic Takes Effect June 3 NEW YORK: Catskill Hospital Warns That Insulin Pens May Have Been Reused DELAWARE: Cape Henlopen Theatre Academy to Host 'Magic to Do' May 25 EUROPE: EU Issues Stringent Sharps Regulations Uganda: HIV Vaccine Trials to Start in July Experimental Gilead drug effective in early-stage leukemia trial Danish researchers issue statement: "We are not on the brink of an HIV cure"TNI BioTech, Inc. Corporation's CEO Issues Letter to Shareholders Discussing Recent Events Sangamo BioSciences Presents Clinical Data Demonstrating HIV Reservoir Reduction in HIV-Infected Subjects Treated with ZFP Therapeutic(R), SB-728-T Jury to be seated, Vegas hep C trial due to start Ascletis Gains China Market Rights from Janssen to a Clinical Stage HIV Protease Inhibitor Women's issues must remain central to sustainable development HIV vaccine trial shut down
Information in this article was accurate in July 30, 1994. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.